메뉴 건너뛰기




Volumn 15, Issue 17, 2007, Pages 5738-5751

1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: Synthesis, analgesic-anti-inflammatory and antimicrobial activities

Author keywords

2 Benzoxazolinone; Analgesic anti inflammatory and antimicrobial activities; Hydrazone; Thiadiazole; Thiosemicarbazide; Triazol

Indexed keywords

1 [2 (5 METHYL 2 BENZOXAZOLINON 3 YL)ACETYL] 4 ALLYLTHIOSEMICARBAZIDE; 1 [2 (5 METHYL 2 BENZOXAZOLINON 3 YL)ACETYL] 4 ETHYLTHIOSEMICARBAZIDE; 1 [2 (5 METHYL 2 BENZOXAZOLINON 3 YL)ACETYL] 4 METHYLTHIOSEMICARBAZIDE; 1 [2 (5 METHYL 2 BENZOXAZOLINON 3 YL)ACETYL] 4 PHENYLTHIOSEMICARBAZIDE; 1,2,4 TRIAZOLE DERIVATIVE; 1,3,4 THIADIAZOLE DERIVATIVE; 2 (5 METHYL 2 BENZOXAZOLINON 3 YL)ACETYLHYDRAZINE; 2 [2 (5 METHYL 2 BENZOXAZOLINON 3 YL)ACETYL] 4 BROMOBENZYLIDENEHYDRAZINE; 2 [2 (5 METHYL 2 BENZOXAZOLINON 3 YL)ACETYL] 4 CHLOROBENZYLIDENEHYDRAZINE; 2 [2 (5 METHYL 2 BENZOXAZOLINON 3 YL)ACETYL] 4 METHOXYBENZYLIDENEHYDRAZINE; 2 [2 (5 METHYL 2 BENZOXAZOLINON 3 YL)ACETYL] 4 METHYLBENZYLIDENEHYDRAZINE; 2 [2 (5 METHYL 2 BENZOXAZOLINON 3 YL)ACETYL]BENZYLIDENEHYDRAZINE; 2 BENZOXAZOLONE DERIVATIVE; 2 ETHYLAMINO 5 [(5 METHYL 2 BENZOXAZOLINON 3 YL)METHYL] 1,3,4 THIADIAZOLE; 2 METHYLAMINO 5 [(5 METHYL 2 BENZOXAZOLINON 3 YL)METHYL] 1,3,4 THIADIAZOLE; 2 PHENYLAMINO 5 [(5 METHYL 2 BENZOXAZOLINON 3 YL)METHYL] 1,3,4 THIADIAZOLE; 3 [(5 METHYL 2 BENZOXAZOLINON 3 YL)METHYL] 4 ALLYL 1H 1,2,4 TRIAZOLE 5(4H) THIONE; 3 [(5 METHYL 2 BENZOXAZOLINON 3 YL)METHYL] 4 ETHYL 1H 1,2,4 TRIAZOLE 5(4H) THIONE; 3 [(5 METHYL 2 BENZOXAZOLINON 3 YL)METHYL] 4 METHYL 1H 1,2,4 TRIAZOLE 5(4H) THIONE; 3 [(5 METHYL 2 BENZOXAZOLINON 3 YL)METHYL] 4 PHENYL 1H 1,2,4 TRIAZOLE 5(4H) THIONE; 5 METHYL 2 BENZOXAZOLINONE DERIVATIVE; AMPICILLIN; BENZYLIDENEHYDRAZINE DERIVATIVE; FLUCONAZOLE; HYDRAZINE DERIVATIVE; HYDRAZONE DERIVATIVE; INDOMETACIN; THIOSEMICARBAZIDE DERIVATIVE; UNCLASSIFIED DRUG;

EID: 34447267965     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.06.006     Document Type: Article
Times cited : (402)

References (69)
  • 42
    • 34447279819 scopus 로고    scopus 로고
    • Kaplanci{dotless}kli{dotless}, Z. A.; Turan-Zitouni, G.; Özdemir, A.; Revial, G. Eur. J. Med. Chem. 2007, in press.
  • 43
    • 34447267598 scopus 로고    scopus 로고
    • Sztanke, K.; Tuzimski, T.; Rzymowska, J.; Pasternak, K.; Kandefer-Szerszen, M. Eur. J. Med. Chem. 2007, in press.
  • 57
    • 34447272386 scopus 로고    scopus 로고
    • Kaynak, F. B.; Eriksson, L.; Gökhan, N.; Salgi{dotless}n, U.; Unpublished results.
  • 63
    • 34447253432 scopus 로고    scopus 로고
    • National Committees for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th Ed., Approved Standard. M7-A4, Wayne, P.A. 1997.
  • 64
    • 34447277280 scopus 로고    scopus 로고
    • National Committees for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts: Approved Standard. M27-A, Wayne, P.A. 1997.
  • 65
    • 34447258298 scopus 로고    scopus 로고
    • Stoe & Cie, X-AREA (Version 1.18) and X-RED32 (Version 1.04). Stoe & Cie, Darmstadt, Germany, 2002.
  • 66
    • 34447292946 scopus 로고    scopus 로고
    • Sheldrick, G.M. SHELXS97. Program for the Solution of Crystal Structure. University of Göttingen, Germany, 1997.
  • 67
    • 34447275605 scopus 로고    scopus 로고
    • Sheldrick, G.M. SHELXL97. Program for the Refinement of Crystal Structures. University of Göttingen, Germany, 1997.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.